Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Ovarian Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Neoplasms Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Tumors Chemical Compounds
Breast Neoplasms Medicine & Life Sciences
Nanotubes Medicine & Life Sciences
Diabetic Foot Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 510 Citations
  • 14 h-Index
  • 26 Article
  • 6 Review article

Direct and indirect P-glycoprotein transfers in MCF7 breast cancer cells

Dyson, J., Foll, F. L., Magal, P., Noussair, A. & Pasquier, J., 14 Jan 2019, In : Journal of Theoretical Biology. 461, p. 239-253 15 p.

Research output: Contribution to journalArticle

Glycoproteins
Glycoprotein
P-Glycoprotein
Breast Cancer
breast neoplasms

Whole-methylome analysis of circulating monocytes in acute diabetic Charcot foot reveals differentially methylated genes involved in the formation of osteoclasts

Pasquier, J., Spurgeon, M., Bradic, M., Thomas, B., Robay, A., Chidiac, O., DIb, M. J., Turjoman, R., Liberska, A., Staudt, M., Fakhro, K. A. M. A., Menzies, R., Jayyousi, A., Zirie, M., Suwaidi, J. A., Malik, R., Talal, T., Tabrizi, A. R., Mezey, J., Rodriguez-Flores, J. & 2 othersCrystal, R. & Abi Khalil, C., 1 Feb 2019, In : Epigenomics. 11, 3, p. 281-296 16 p.

Research output: Contribution to journalArticle

Diabetic Foot
Osteoclasts
Monocytes
Type 2 Diabetes Mellitus
Foot
7 Citations (Scopus)

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer

Pasquier, J., Gosset, M., Geyl, C., Hoarau, J., Chevrot, A., Pocard, M., Mirshahi, M., Lis, R., Tabrizi, A. R. & Touboul, C., 19 Feb 2018, In : Molecular Cancer. 17, 1, 47.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Interleukin-6
Mesenchymal Stromal Cells
Residual Neoplasm
Drug Therapy